These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 240271)
1. Characterization of Hex S, the major residual beta hexosaminidase activity in type O Gm2 gangliosidosis (Sandhoff-Jatzkewitz disease). Ikonne JU; Rattazzi MC; Desnick RJ Am J Hum Genet; 1975 Sep; 27(5):639-50. PubMed ID: 240271 [TBL] [Abstract][Full Text] [Related]
2. Hexosaminidase isozyme in type O Gm2 gangliosidosis (Sandhoff-Jatzkewitz disease). Beutler E; Kuhl W; Comings D Am J Hum Genet; 1975 Sep; 27(5):628-38. PubMed ID: 808963 [TBL] [Abstract][Full Text] [Related]
3. Studies on complementation of beta hexosaminidase deficiency in human GM2 gangliosidosis. Rattazzi MC; Brown JA; Davidson RG; Shows TB Am J Hum Genet; 1976 Mar; 28(2):143-54. PubMed ID: 817596 [TBL] [Abstract][Full Text] [Related]
4. Juvenile Sandhoff disease: some properties of the residual hexosaminidase in cultured fibroblasts. Wood S; MacDougall BG Am J Hum Genet; 1976 Sep; 28(5):489-95. PubMed ID: 10724 [TBL] [Abstract][Full Text] [Related]
5. [Genetic study of GM2 gangliosidosis (Tay-Sachs and Sandhoff) by the study of the hexosaminidases of the Sandhoff-rodents hybrids (mouse and hamster)]. Weil D; Van Cong N; Rebourcet R; Frézal J Ann Genet; 1975 Sep; 18(3):163-8. PubMed ID: 810067 [TBL] [Abstract][Full Text] [Related]
6. Immunochemical and biochemical investigation of hexosaminidase S. Geiger B; Arnon R; Sandhoff K Am J Hum Genet; 1977 Sep; 29(5):508-22. PubMed ID: 409285 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of 4-methylumbelliferyl-beta-D-N-acetylglucosamine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes. Bayleran J; Hechtman P; Saray W Clin Chim Acta; 1984 Nov; 143(2):73-89. PubMed ID: 6239713 [TBL] [Abstract][Full Text] [Related]
8. Antigenic homology of feline and human beta-hexosaminidase. O'Neil DC; Bartholomew WR; Rattazzi MC Biochim Biophys Acta; 1979 Sep; 580(1):1-9. PubMed ID: 94833 [TBL] [Abstract][Full Text] [Related]
9. A study of hexosaminadases in interspecific hybrids and in GM2 gangliosidosis with a discussion on their genetic control. Van Cong N; Weil D; Rebourcet R; Frézal J; Richard-Mollard AM Ann Hum Genet; 1975 Jul; 39(1):111-23. PubMed ID: 810068 [TBL] [Abstract][Full Text] [Related]
10. The tissue distribution of hexosaminidase S and hexosaminidase C. Beutler E; Kuhl W Ann Hum Genet; 1977 Oct; 41(2):163-7. PubMed ID: 413470 [TBL] [Abstract][Full Text] [Related]
11. Laboratory diagnosis of canine GM2-gangliosidosis using blood and cerebrospinal fluid. Yamato O; Satoh H; Matsuki N; Ono K; Yamasaki M; Maede Y J Vet Diagn Invest; 2004 Jan; 16(1):39-44. PubMed ID: 14974845 [TBL] [Abstract][Full Text] [Related]
12. Canine GM2-Gangliosidosis Sandhoff Disease Associated with a 3-Base Pair Deletion in the HEXB Gene. Wang P; Henthorn PS; Galban E; Lin G; Takedai T; Casal M J Vet Intern Med; 2018 Jan; 32(1):340-347. PubMed ID: 29106755 [TBL] [Abstract][Full Text] [Related]
13. Hexosaminidase C in brain affected by Tay-Sachs Disease. Minami R; Nakamura F; Oyanagi K; Nakao T Tohoku J Exp Med; 1981 Feb; 133(2):175-85. PubMed ID: 7268761 [TBL] [Abstract][Full Text] [Related]
14. Juvenile GM2 gangliosidosis (AMB variant): inability to activate hexosaminidase A by activator protein. Inui K; Grebner EE; Jackson LG; Wenger DA Am J Hum Genet; 1983 Jul; 35(4):551-64. PubMed ID: 6224417 [TBL] [Abstract][Full Text] [Related]
15. Validity of lymphoid cell line for enzymatic studies of GM2-gangliosidosis variant 0 (Sandhoff disease). Maret A; Salvayre R; Radon J; Hardy M; Vuillaume M; Lenoir G; Douste-Blazy L Enzyme; 1985; 34(1):48-56. PubMed ID: 3002784 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis of infantile and juvenile forms of GM2 gangliosidosis variant 0. Residual activities toward natural and different synthetic substrates. Kytzia HJ; Hinrichs U; Sandhoff K Hum Genet; 1984; 67(4):414-8. PubMed ID: 6436167 [TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus transformed lymphoid cell lines as a new model system in culture for the study of GM2-gangliosidoses: Tay-Sachs and Sandhoff diseases. Maret A; Salvayre R; Negre A; Bes JC; Douste-Blazy L Biol Cell; 1985; 53(3):293-6. PubMed ID: 2990625 [TBL] [Abstract][Full Text] [Related]
18. Thermodynamic determination of plasma and leukocyte beta-hexosaminidase isoenzymes in homozygote and heterozygote carriers for the GM2 gangliosidosis B1 variant. Casal JA; Pérez LF; Tutor JC Am J Clin Pathol; 2003 May; 119(5):684-8. PubMed ID: 12760286 [TBL] [Abstract][Full Text] [Related]
19. Characterization and tissue distribution of N-acetyl hexosaminidase C: suggestive evidence for a separate hexosaminidase locus. Swallow DM; Evans L; Saha N; Harris H Ann Hum Genet; 1976 Jul; 40(1):55-66. PubMed ID: 9025 [TBL] [Abstract][Full Text] [Related]
20. Prenatal diagnosis of GM2 gangliosidosis with high residual hexosaminidase A activity (variant B1; pseudo AB variant). Conzelmann E; Nehrkorn H; Kytzia HJ; Sandhoff K; Macek M; Lehovský M; Elleder M; Jirásek A; Kobilková J Pediatr Res; 1985 Nov; 19(11):1220-4. PubMed ID: 2933632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]